Armistice Capital »

Novo Nordisk A/S shares owned by Armistice Capital

Quarter-by-quarter ownership of Novo Nordisk A/S (NVO) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Novo Nordisk A/S

Tip: Access up to 7 years of quarterly data

All positions including Novo Nordisk A/S held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novo Nordisk A/S by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $40M 436k 90.94
2023-06-30 $44M 270k 161.83
2023-03-31 $47M 292k 159.14
2022-12-31 $42M 312k 135.34

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Argenx Se Sponsored Adr (ARGX)
Supernus Pharmaceuticals (SUPN)
Ptc Therapeutics I (PTCT)
Neurocrine Biosciences (NBIX)
Agios Pharmaceuticals (AGIO)
Biogen Idec (BIIB)
Colgate-Palmolive Company (CL)
Travere Therapeutics (TVTX)
Nevro (NVRO)
Amazon (AMZN)
Dentsply Sirona (XRAY)
Regeneron Pharmaceuticals (REGN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Armistice Capital

Top funds holding Novo Nordisk A/S

Jennison Associates
Fisher Investments
Bank of America Corporation
Fayez Sarofim & Co
Folketrygdfondet
Polen Capital Management
T. Rowe Price Associates
Everett Harris & Co
State Farm Mutual Automobile Insurance Company
Goldman Sachs Group
Jpmorgan Chase & Co
WCM Investment Management
Sustainable Growth Advisers
Wells Fargo & Company
Royal Bank of Canada

View all funds holding Novo Nordisk A/S